MENU
MENU
About Us
Statement From CEO
Our Leadership
Partnerships
Programs
Cancer Immunotherapy
SARS-CoV-2 Vaccine
Retinal Degeneration
Publications
News & Media
Contact Us
MENU
MENU
About Us
Statement From CEO
Our Leadership
Partnerships
Programs
Cancer Immunotherapy
SARS-CoV-2 Vaccine
Retinal Degeneration
Publications
News & Media
Contact Us
June 2016
AiVita Biomedical Receives FDA Approval for Phase II Ovarian Cancer Treatment